Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,509 | 5,444 | 94 | 416 | 248 |
| Receivables | 1,366 | 871 | 1,585 | 656 | 1,807 |
| Other current assets | 197 | 0 | 21 | 28 | 51 |
| TOTAL | $6,228 | $6,381 | $1,745 | $1,173 | $2,216 |
| Non-Current Assets | |||||
| Investments And Advances | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $32 | $32 | $32 | $32 | $32 |
| Total Assets | $6,260 | $6,413 | $1,777 | $1,205 | $2,248 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,031 | 796 | 1,598 | 1,465 | 1,761 |
| TOTAL | $1,236 | $796 | $2,622 | $1,494 | $1,814 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 205 | 0 | 22 | 29 | 53 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,236 | $796 | $2,622 | $1,494 | $1,814 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 151,560 | 151,560 | 151,560 | 135,930 | 135,850 |
| Common Shares | 1,515 | 1,515 | 1,359 | 1,359 | 1,359 |
| Retained earnings | -188,293 | -187,663 | -186,630 | -186,196 | -185,411 |
| Other shareholders' equity | 5 | 5 | 5 | 5 | 5 |
| TOTAL | $5,024 | $5,617 | $-845 | $-289 | $434 |
| Total Liabilities And Equity | $6,260 | $6,413 | $1,777 | $1,205 | $2,248 |